Mer, HerVaxx had been designed to stimulate the immune system and that has been the case in C3. That's the most important fact for IMU and pharma. Of course a weakened immune system may response less or not at all or stops to respond.
We don't know the patient's circumstances and the state of their health. Therefore I stick with the proof that HerVaxx is working but of course individual results will always vary. Current T-cell drugs have an impact on about 20% of treated patients and that is enough to make pharma $ billons. Compared to that the Ph1 results are incredible even if not all candidates got the desired outcome.
GLTA
Mer, HerVaxx had been designed to stimulate the immune system...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |